Avacopan with combined cyclophosphamide and rituximab for induction therapy in severe ANCA-associated vasculitis: retrospective observational study of 30 patients in two German referral centres.
- DOI
- 10.55563/clinexprheumatol/7sz0zp
- Published
- 2026 Apr
- Container
- Clinical and experimental rheumatology
- Publisher
- Not recorded
- Open access
- unknown
Credibility signals
limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.55563/clinexprheumatol/7sz0zp,
title = {Avacopan with combined cyclophosphamide and rituximab for induction therapy in severe ANCA-associated vasculitis: retrospective observational study of 30 patients in two German referral centres.},
author = {Assmann G and Adjailia EB and Klapa S and von Allwörden K and Amann K and Turkiewicz R and Radermacher J and Lamprecht P},
year = {2026},
journal = {Clinical and experimental rheumatology},
doi = {10.55563/clinexprheumatol/7sz0zp},
url = {https://doi.org/10.55563/clinexprheumatol/7sz0zp}
}RIS
TY - JOUR TI - Avacopan with combined cyclophosphamide and rituximab for induction therapy in severe ANCA-associated vasculitis: retrospective observational study of 30 patients in two German referral centres. AU - Assmann G AU - Adjailia EB AU - Klapa S AU - von Allwörden K AU - Amann K AU - Turkiewicz R AU - Radermacher J AU - Lamprecht P PY - 2026 JO - Clinical and experimental rheumatology DO - 10.55563/clinexprheumatol/7sz0zp UR - https://doi.org/10.55563/clinexprheumatol/7sz0zp ER -
APA
G, A., EB, A., S, K., K, V. A., K, A., R, T., J, R., & P, L. (2026). Avacopan with combined cyclophosphamide and rituximab for induction therapy in severe ANCA-associated vasculitis: retrospective observational study of 30 patients in two German referral centres.. Clinical and experimental rheumatology. https://doi.org/10.55563/clinexprheumatol/7sz0zp
Source records
- pubmed · retrieved 2026-09-26T07:45:58.986Z